| Efficacy of rapamycin against glioblastoma cancer stem cells M Mendiburu-Eliçabe, J Gil-Ranedo, M Izquierdo Clinical and Translational Oncology 16, 495-502, 2014 | 47 | 2014 |
| Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells I López-Valero, D Dávila, J González-Martínez, N Salvador-Tormo, ... Theranostics 10 (11), 5120, 2020 | 30 | 2020 |
| An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells J Gil-Ranedo, M Mendiburu-Eliçabe, M García-Villanueva, D Medina, ... PLoS One 6 (12), e28753, 2011 | 19 | 2011 |
| Stromal SNAI2 is required for ERBB2 breast cancer progression A Blanco-Gómez, L Hontecillas-Prieto, R Corchado-Cobos, ... Cancer research 80 (23), 5216-5230, 2020 | 18 | 2020 |
| Pathophysiological integration of metabolic reprogramming in breast cancer R Corchado-Cobos, N García-Sancha, M Mendiburu-Eliçabe, ... Cancers 14 (2), 322, 2022 | 12 | 2022 |
| Combination therapy of intraperitoneal rapamycin and convection-enhanced delivery of nanoliposomal CPT-11 in rodent orthotopic brain tumor xenografts M Mendiburu-Eliçabe, J Gil-Ranedo Current Cancer Drug Targets 15 (4), 352-362, 2015 | 11 | 2015 |
| Systemic rapamycin alone may not be a treatment option for malignant glioma: evidence from an in vivo study M Mendiburu-Eliçabe, D Yin, P Hadaczek, Y Zhai, J Forsayeth, ... Journal of neuro-oncology 108, 53-58, 2012 | 10 | 2012 |
| The Pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer A Orea-Soufi, S Castillo-Lluva, N Salvador-Tormo, P Martín-Cabrera, ... Cancers 13 (21), 5307, 2021 | 8 | 2021 |
| From mouse to human: cellular morphometric subtype learned from mouse mammary tumors provides prognostic value in human breast cancer H Chang, X Yang, J Moore, XP Liu, KY Jen, AM Snijders, L Ma, W Chou, ... Frontiers in Oncology 11, 819565, 2022 | 5 | 2022 |
| Circular troughs in tessera terrain on Venus: Morphometry, structural analysis and possible formation model G Cofrade, M Mendiburu-Eliçabe, I Romeo Planetary and Space Science 178, 104706, 2019 | 3 | 2019 |
| POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1 A Martínez‐López, A García‐Casas, G Infante, M González‐Fernández, ... Molecular Oncology 18 (3), 620-640, 2024 | 1 | 2024 |
| TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study J Cañueto, LA Corchete-Sánchez, CD Schmults, N García-Sancha, ... Journal of the European Academy of Dermatology and Venereology: JEADV 37 (4 …, 2023 | 1 | 2023 |
| CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis M Rodrigo-Faus, A Vincelle-Nieto, N Vidal, J Puente, M Saiz-Pardo, ... Cancer Letters, 216776, 2024 | | 2024 |
| Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human N García-Sancha, R Corchado-Cobos, A Blanco-Gómez, OC Puértolas, ... Research Square, 2024 | | 2024 |
| Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human J Pérez-Losada, N García-Sancha, R Corchado-Cobos, A Blanco-Gómez, ... | | 2024 |
| NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence M Mendiburu‐Eliçabe, N García‐Sancha, R Corchado‐Cobos, ... Clinical and Translational Medicine 14 (2), e1554, 2024 | | 2024 |
| CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel driver of metastasis in prostate cancer A Gutierrez-Uzquiza, M Rodrigo-Faus, A Vincelle-Nieto, N Vidal, J Puente, ... | | 2023 |
| A 10-gene signature associated with elevated levels of NCAPH identifies luminal A breast cancer patients with a risk of relapse M Mendiburu-Eliçabe, N García-Sancha, R Corchado-Cobos, ... | | 2023 |
| Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk A Gómez-Vecino, R Corchado-Cobos, A Blanco-Gómez, ... Cells 12 (15), 1956, 2023 | | 2023 |
| Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. Cells 2023, 12, 1956 A Gómez-Vecino, R Corchado-Cobos, A Blanco-Gómez, ... | | 2023 |
